DOCSLIB.ORG

Interaction of Colon Cancer Cells with Glycoconjugates Triggers Complex Changes in Gene Expression, Glucose Transporters and Cell Invasion

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Interaction of Colon Cancer Cells with Glycoconjugates Triggers Complex Changes in Gene Expression, Glucose Transporters and Cell Invasion 5508 MOLECULAR MEDICINE REPORTS 17: 5508-5517, 2018 Interaction of colon cancer cells with glycoconjugates triggers complex changes in gene expression, glucose transporters and cell invasion ROMANA KŘIVOHLAVÁ, VALIKA GROBÁROVÁ, EVA NEUHÖFEROVÁ, ANNA FIŠEROVÁ and VERONIKA BENSON Laboratory of Molecular Biology and Immunology, Department of Immunology, Institute of Microbiology, Czech Academy of Sciences, 14220 Prague 4, Czech Republic Received September 21, 2017; Accepted December 15, 2017 DOI: 10.3892/mmr.2018.8490 Abstract. Glycan metabolism balance is critical for cell pros- mRNA expression in a comprehensive way, resulting in the perity, and macromolecule glycosylation is essential for cell reduced malignant phenotype of the colon cancer cell line communication, signaling and survival. Thus, glycotherapy HT-29. may be a potential cancer treatment. The aim of the present study was to determine whether combined synthetic glycocon- Introduction jugates (GCs) induce changes in gene expression that alter the survival of colon cancer cells. The current study evaluated the Cell surface glycans are molecules that regulate interac- effect of the GCs N‑acetyl‑D‑glucosamine modified polyami- tions among neighboring cells or contact between cells and doamine dendrimer and calix[4]arene scaffold on cancer cell the extracellular matrix during cell adhesion, recognition proliferation, apoptosis, invasion and sensitivity to immune and communication (1). An aberrant glycosylation pattern cell-mediated killing. Using reverse transcription-quantitative promotes the development and progression of certain patholo- polymerase chain reaction, the expression of genes involved in gies, including cancer (1). Glycan alterations may result in the aforementioned processes was measured. It was determined tumor development and progression, as well as tumor-cell that GCs reduce the expression of the glucosaminyltransfer- dissociation and invasion, which subsequently promote metas- ases Mgat3 and Mgat5 responsible for surface glycosylation tasis and tumor-associated neoangiogenesis (2). Importantly, and employed components of the Wnt signaling pathway aberrant glycosylation of the tumor cell surface results in the Wnt2B and Wnt9B. In addition, the calix[4]arene-based GC impairment of its recognition by cells of the immune system, reduced cell colony formation; this was accompanied by the including natural killer (NK) cells (2,3). downregulation of the metalloproteinase Mmp3. By contrast, Alterations in glycosylation primarily arise from changes in the the dendrimer-based GC affected the expression of the glucose expression of N-acetyl-D-glucosamine (GlcNAc) transferases in transporter components Sglt1 and Egfr1. Therefore, to the best the Golgi system (4). The family of β-1,4-mannosyl-glycoprotein of our knowledge, the present study is the first to reveal that 4-β-N-acetyl glucosaminyltransferases consists of several N-acetyl-D-glucosamine-dendrimer/calix[4]arene GCs alter members, including Mgat3 and Mgat5, which are involved in linking terminal residues to glycans on the cell surface. The competition between Mgat3 and Mgat5 results in the branching or bisecting of surface glycans and this final pattern influences Correspondence to: Dr Veronika Benson, Laboratory of intercellular recognition (5). Mgat5 is responsible for adding Molecular Biology and Immunology, Department of Immunology, β1-6 GlcNAc residues and forming branched structures, which Institute of Microbiology, Czech Academy of Sciences, are particularly abundant in cancer tissues with high metastatic Vídeňská 1083, 14220 Prague 4, Czech Republic potential (4). Mgat3 facilitates the addition of β1-4 GlcNAc E-mail: [email protected] residues and constructs a bisecting structure that inhibits further addition of GlcNAc by other glucosaminyltransferases, including Abbreviations: GC, glycoconjugate; GlcNAc, N-acetylglucosamine; Mgat5 (6). Mgat3 and Mgat5 enzymes tend to be overexpressed GN4C, N-acetyl-D-glucosamine-coated calix[4]arene; GN8P, in tumor cells (2,7). Song et al (8) reported that bisecting N-acetyl-D-glucosamine-coated polyamidoamine dendrimer; PAMAM, polyamidoamine; PBMC, peripheral blood mononuclear GlcNAc on N-glycans inhibits the signaling of growth factors cells; RTCA, Real-Time Cell Analyzer and attenuates the progression of mammary tumors. Therefore, the resulting effect of Mgat3/Mgat5 activity is likely to be tumor Key words: calix[4]arene, polyamidoamine dendrimer, glycosylation, specific. The expression of Mgat5 is regulated via the NM23 N-acetyl-glucosaminyl-transferase, WNT, colon cancer cell regulator, which is encoded by Nme1 gene (9) and the expres- sion of glucosaminyltransferases, including Mgat3 and Mgat5, is associated with their surface glycosylation activity (10). KŘIVOHLAVÁ et al: GLYCOCONJUGATES TRIGGER COMPLEX CHANGES IN COLON CANCER CELLS 5509 In vitro, cell glycosylation may be studied using synthetic VA, USA) and was authenticated following the guidelines glycoconjugates (GCs) that modulate cell surface glycosyl- of the International Cell Line Authentication Committee ation. GCs are able to interfere with cancer cell processes and (https://www.lgcstandards-atcc.org). Cells were maintained the cancer microenvironment; therefore they may be able to in 37˚C and in an RPMI‑1640 medium with 10% fetal calf modulate the malignant phenotype of cancer cells (11). serum (Sigma-Aldrich, Merck KGaA, Darmstadt, Germany). The present study focused on GC-triggered alterations Peripheral blood mononuclear cells (PBMC) were obtained in the mRNA expression of surface glycosylation regulators, from peripheral blood of healthy donors (4 males, mean as well as key components of signaling pathways responsible age 46.3±9.4; samples collected August 2012) using a for cell-extracellular matrix adhesion, neovascularization Ficoll‑Paque (GE Healthcare Life Sciences, Little Chalfont, and invasion, each of which contribute to the metastatic UK) at density 1,077 g/ml and centrifugation for 40 min at potential of cancer cells. The GCs assessed included GlcNAc room temperature and 400 x g. Blood samples were taken moieties linked with a calix[4]arene or with a polyamido- from material remaining following a routine donor check-up amine dendrimer (PAMAM) core. Calix[4]arenes possessing at the transfusion unit of the Thomayer Hospital (Prague, distinctive geometry act as carriers of anticancer drugs (12) or Czech Republic). All donors signed informed consent for the as direct anticancer agents via enzyme inhibition (13), angio- use of their blood for experimental purposes. The current genesis inhibition (14) or innate immunity modulation (15). study was approved by the Ethical Committee of Thomayer PAMAM dendrimers have previously been used to deliver Hospital. The chemically defined GC calix[4]arene containing genes and drugs (16). of four terminal N-acetyl-D-glucosamine moieties (GN4C) Cells internalize exogenous glucosamine via the glucose was synthesized and kindly provided by Vladimir Křen and transporter and process it, as well as cellular glucosamine, Karel Křenek (Czech Academy of Sciences, Prague, Czech via lysosomal degradation into uridine diphosphate glucose Republic). A GC consisting of PAMAM with eight terminal (UDP)-GlcNAc (17,18). This UDP-GlcNAc is further used in N-acetyl-D-glucosamine moieties (GN8P) was synthe- the post‑transcriptional modification of glycosylate substrates, sized and kindly provided by Thisbe Lindhorst (Christiana such as proteins. Glycosylation of nuclear proteins, including Albertina University, Kiel, Germany). The synthesis, purity, histone H2B, contributes to transcriptional regulation (19). nuclear magnetic resonance data and dose-dependent effect The genes encoding the sodium glucose cotransporter 1 of the GCs on human PBMC cells have been previously (Sglt1) and epidermal growth factor receptor (Egfr1) are described (2,24-26). The optimal concentration of 10 nM components of a glucose co-transporter. Sglt1 is expressed GN4C or GN8P were used for the experiments. Fludara® primarily in the human intestine and kidney (20). An example (1 mM, FLU; Genzyme, Cambridge, MA, USA), which is a of a Egfr1 ligand is N-acetylglucosamine (21). Glycosylation conventional anticancer drug, was used to compare the anti- of the epidermal growth factor receptor improves its ability to cancer effect of the tested GCs with a known anticancer agent. bind to epidermal growth factor (22). The coupling of Egfr1 to Sglt1 further stabilizes the whole complex and enables cancer Glyco‑gene profiling array. The HT-29 cell line was cells to take up high levels of glucose (23). incubated with GN8P for 24 h and total RNA was isolated The authors of the present study previously reported using an RNAeasy Mini kit involving DNAse I treatment that a GC consisting of four GlcNAc residues on a following the manufacturer's protocol (DNAse I was a N-acetyl-D-glucosamine-coated calix[4]arene core (GN4C) component of RNAeasy Mini kit; Qiagen GmbH, Hilden, alters the glycosylation of human NK cells and promotes the Germany). A Glyco-gene Chip array (GLYCOv3 Gene cell-mediated cytotoxicity of human NK cells against K562 Chip; Affymetrix; Thermo Fisher Scientific, Inc., altham,W and HT-29 target cells via the phosphoinositide 3-kinase MA, USA) containing probe sets of 2,000 human tran- pathway (2). In addition, it has been demonstrated that a scripts was provided by the Consortium for Functional GC consisting of eight GlcNAc residues on a PAMAM core Glycomics (http://www.functionalglycomics.org/static/consor-
Load more

Recommended publications
  • Supplementary Information Integrative Analyses of Splicing in the Aging Brain: Role in Susceptibility to Alzheimer’S Disease
    Supplementary Information Integrative analyses of splicing in the aging brain: role in susceptibility to Alzheimer’s Disease Contents 1. Supplementary Notes 1.1. Religious Orders Study and Memory and Aging Project 1.2. Mount Sinai Brain Bank Alzheimer’s Disease 1.3. CommonMind Consortium 1.4. Data Availability 2. Supplementary Tables 3. Supplementary Figures Note: Supplementary Tables are provided as separate Excel files. 1. Supplementary Notes 1.1. Religious Orders Study and Memory and Aging Project Gene expression data1. Gene expression data were generated using RNA- sequencing from Dorsolateral Prefrontal Cortex (DLPFC) of 540 individuals, at an average sequence depth of 90M reads. Detailed description of data generation and processing was previously described2 (Mostafavi, Gaiteri et al., under review). Samples were submitted to the Broad Institute’s Genomics Platform for transcriptome analysis following the dUTP protocol with Poly(A) selection developed by Levin and colleagues3. All samples were chosen to pass two initial quality filters: RNA integrity (RIN) score >5 and quantity threshold of 5 ug (and were selected from a larger set of 724 samples). Sequencing was performed on the Illumina HiSeq with 101bp paired-end reads and achieved coverage of 150M reads of the first 12 samples. These 12 samples will serve as a deep coverage reference and included 2 males and 2 females of nonimpaired, mild cognitive impaired, and Alzheimer's cases. The remaining samples were sequenced with target coverage of 50M reads; the mean coverage for the samples passing QC is 95 million reads (median 90 million reads). The libraries were constructed and pooled according to the RIN scores such that similar RIN scores would be pooled together.
    [Show full text]
  • Supplementary Table 3 Complete List of RNA-Sequencing Analysis of Gene Expression Changed by ≥ Tenfold Between Xenograft and Cells Cultured in 10%O2
    Supplementary Table 3 Complete list of RNA-Sequencing analysis of gene expression changed by ≥ tenfold between xenograft and cells cultured in 10%O2 Expr Log2 Ratio Symbol Entrez Gene Name (culture/xenograft) -7.182 PGM5 phosphoglucomutase 5 -6.883 GPBAR1 G protein-coupled bile acid receptor 1 -6.683 CPVL carboxypeptidase, vitellogenic like -6.398 MTMR9LP myotubularin related protein 9-like, pseudogene -6.131 SCN7A sodium voltage-gated channel alpha subunit 7 -6.115 POPDC2 popeye domain containing 2 -6.014 LGI1 leucine rich glioma inactivated 1 -5.86 SCN1A sodium voltage-gated channel alpha subunit 1 -5.713 C6 complement C6 -5.365 ANGPTL1 angiopoietin like 1 -5.327 TNN tenascin N -5.228 DHRS2 dehydrogenase/reductase 2 leucine rich repeat and fibronectin type III domain -5.115 LRFN2 containing 2 -5.076 FOXO6 forkhead box O6 -5.035 ETNPPL ethanolamine-phosphate phospho-lyase -4.993 MYO15A myosin XVA -4.972 IGF1 insulin like growth factor 1 -4.956 DLG2 discs large MAGUK scaffold protein 2 -4.86 SCML4 sex comb on midleg like 4 (Drosophila) Src homology 2 domain containing transforming -4.816 SHD protein D -4.764 PLP1 proteolipid protein 1 -4.764 TSPAN32 tetraspanin 32 -4.713 N4BP3 NEDD4 binding protein 3 -4.705 MYOC myocilin -4.646 CLEC3B C-type lectin domain family 3 member B -4.646 C7 complement C7 -4.62 TGM2 transglutaminase 2 -4.562 COL9A1 collagen type IX alpha 1 chain -4.55 SOSTDC1 sclerostin domain containing 1 -4.55 OGN osteoglycin -4.505 DAPL1 death associated protein like 1 -4.491 C10orf105 chromosome 10 open reading frame 105 -4.491
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Macropinocytosis Requires Gal-3 in a Subset of Patient-Derived Glioblastoma Stem Cells
    ARTICLE https://doi.org/10.1038/s42003-021-02258-z OPEN Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells Laetitia Seguin1,8, Soline Odouard2,8, Francesca Corlazzoli 2,8, Sarah Al Haddad2, Laurine Moindrot2, Marta Calvo Tardón3, Mayra Yebra4, Alexey Koval5, Eliana Marinari2, Viviane Bes3, Alexandre Guérin 6, Mathilde Allard2, Sten Ilmjärv6, Vladimir L. Katanaev 5, Paul R. Walker3, Karl-Heinz Krause6, Valérie Dutoit2, ✉ Jann N. Sarkaria 7, Pierre-Yves Dietrich2 & Érika Cosset 2 Recently, we involved the carbohydrate-binding protein Galectin-3 (Gal-3) as a druggable target for KRAS-mutant-addicted lung and pancreatic cancers. Here, using glioblastoma patient-derived stem cells (GSCs), we identify and characterize a subset of Gal-3high glio- 1234567890():,; blastoma (GBM) tumors mainly within the mesenchymal subtype that are addicted to Gal-3- mediated macropinocytosis. Using both genetic and pharmacologic inhibition of Gal-3, we showed a significant decrease of GSC macropinocytosis activity, cell survival and invasion, in vitro and in vivo. Mechanistically, we demonstrate that Gal-3 binds to RAB10, a member of the RAS superfamily of small GTPases, and β1 integrin, which are both required for macro- pinocytosis activity and cell survival. Finally, by defining a Gal-3/macropinocytosis molecular signature, we could predict sensitivity to this dependency pathway and provide proof-of- principle for innovative therapeutic strategies to exploit this Achilles’ heel for a significant and unique subset of GBM patients. 1 University Côte d’Azur, CNRS UMR7284, INSERM U1081, Institute for Research on Cancer and Aging (IRCAN), Nice, France. 2 Laboratory of Tumor Immunology, Department of Oncology, Center for Translational Research in Onco-Hematology, Swiss Cancer Center Léman (SCCL), Geneva University Hospitals, University of Geneva, Geneva, Switzerland.
    [Show full text]
  • Screening and Identification of Hub Genes in Bladder Cancer by Bioinformatics Analysis and KIF11 Is a Potential Prognostic Biomarker
    ONCOLOGY LETTERS 21: 205, 2021 Screening and identification of hub genes in bladder cancer by bioinformatics analysis and KIF11 is a potential prognostic biomarker XIAO‑CONG MO1,2*, ZI‑TONG ZHANG1,3*, MENG‑JIA SONG1,2, ZI‑QI ZHOU1,2, JIAN‑XIONG ZENG1,2, YU‑FEI DU1,2, FENG‑ZE SUN1,2, JIE‑YING YANG1,2, JUN‑YI HE1,2, YUE HUANG1,2, JIAN‑CHUAN XIA1,2 and DE‑SHENG WENG1,2 1State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine; 2Department of Biotherapy, Sun Yat‑Sen University Cancer Center; 3Department of Radiation Oncology, Sun Yat‑Sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China Received July 31, 2020; Accepted December 18, 2020 DOI: 10.3892/ol.2021.12466 Abstract. Bladder cancer (BC) is the ninth most common immunohistochemistry and western blotting. In summary, lethal malignancy worldwide. Great efforts have been devoted KIF11 was significantly upregulated in BC and might act as to clarify the pathogenesis of BC, but the underlying molecular a potential prognostic biomarker. The present identification mechanisms remain unclear. To screen for the genes associated of DEGs and hub genes in BC may provide novel insight for with the progression and carcinogenesis of BC, three datasets investigating the molecular mechanisms of BC. were obtained from the Gene Expression Omnibus. A total of 37 tumor and 16 non‑cancerous samples were analyzed to Introduction identify differentially expressed genes (DEGs). Subsequently, 141 genes were identified, including 55 upregulated and Bladder cancer (BC) is the ninth most common malignancy 86 downregulated genes. The protein‑protein interaction worldwide with substantial morbidity and mortality.
    [Show full text]
  • Comparative Biochemistry and Physiology, Part D, Vol. 5, Pp. 45-54 (2010)
    Comparative genomics and proteomics of vertebrate diacylglycerol acyltransferase (DGAT), acyl CoA wax alcohol acyltransferase (AWAT) and monoacylglycerol acyltransferase (MGAT) Author Holmes, Roger S Published 2010 Journal Title Comparative Biochemistry and Physiology, Part D DOI https://doi.org/10.1016/j.cbd.2009.09.004 Copyright Statement © 2010 Elsevier. This is the author-manuscript version of this paper. Reproduced in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version. Downloaded from http://hdl.handle.net/10072/36786 Griffith Research Online https://research-repository.griffith.edu.au Comparative Biochemistry and Physiology, Part D, Vol. 5, pp. 45-54 (2010) COMPARATIVE GENOMICS AND PROTEOMICS OF VERTEBRATE DIACYLGLYCEROL ACYLTRANSFERASE (DGAT), ACYL CoA WAX ALCOHOL ACYLTRANSFERASE (AWAT) AND MONOACYLGLYCEROL ACYLTRANSFERASE (MGAT) Roger S Holmes School of Biomolecular and Physical Sciences, Griffith University, Nathan 4111 Brisbane Queensland Australia Email: [email protected] Keywords: Diacylglycerol acyltransferase-Monoacylglycerol transferase-Human- Mouse-Opossum-Zebrafish-Genetics-Evolution-X chromosome Running Head: Genomics and proteomics of vertebrate acylglycerol acyltransferases ABSTRACT BLAT (BLAST-Like Alignment Tool) analyses of the opossum (Monodelphis domestica) and zebrafish (Danio rerio) genomes were undertaken using amino acid sequences of the acylglycerol acyltransferase (AGAT) superfamily. Evidence is reported for 8 opossum monoacylglycerol acyltransferase-like (MGAT) (E.C. 2.3.1.22) and diacylglycerol acyltransferase-like (DGAT) (E.C. 2.3.1.20) genes and proteins, including DGAT1, DGAT2, DGAT2L6 (DGAT2-like protein 6), AWAT1 (acyl-CoA wax alcohol acyltransferase 1), AWAT2, MGAT1, MGAT2 and MGAT3. Three of these genes (AWAT1, AWAT2 and DGAT2L6) are closely localized on the opossum X chromosome.
    [Show full text]
  • Chloride Channels Regulate Differentiation and Barrier Functions
    RESEARCH ARTICLE Chloride channels regulate differentiation and barrier functions of the mammalian airway Mu He1†*, Bing Wu2†, Wenlei Ye1, Daniel D Le2, Adriane W Sinclair3,4, Valeria Padovano5, Yuzhang Chen6, Ke-Xin Li1, Rene Sit2, Michelle Tan2, Michael J Caplan5, Norma Neff2, Yuh Nung Jan1,7,8, Spyros Darmanis2*, Lily Yeh Jan1,7,8* 1Department of Physiology, University of California, San Francisco, San Francisco, United States; 2Chan Zuckerberg Biohub, San Francisco, United States; 3Department of Urology, University of California, San Francisco, San Francisco, United States; 4Division of Pediatric Urology, University of California, San Francisco, Benioff Children’s Hospital, San Francisco, United States; 5Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Heaven, United States; 6Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, United States; 7Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States; 8Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, United States *For correspondence: Abstract The conducting airway forms a protective mucosal barrier and is the primary target of [email protected] (MH); [email protected] airway disorders. The molecular events required for the formation and function of the airway (SD); mucosal barrier, as well as the mechanisms by which barrier dysfunction leads to early onset airway [email protected] (LYJ) diseases,
    [Show full text]
  • 3313.Full.Pdf
    [CANCER RESEARCH Vol. 6, 3313–3319, June 15, 2000] New Evidence for an Extra-Hepatic Role of N-acetylglucosaminyltransferase III in the Progression of Diethylnitrosamine-induced Liver Tumors in Mice1 Xiaoping Yang, Mantu Bhaumik, Riddhi Bhattacharyya, Shih Gong, Charles E. Rogler, and Pamela Stanley2 Departments of Cell Biology [X. Y., M. B., R. B., P. S.] and Medicine and Microbiology/Immunology [S. G., C. E. R.], Albert Einstein College of Medicine, New York, New York 10461 ABSTRACT exhibit reduced experimental metastasis (10). Overexpression of Gl- cNAc-TIII in PC12 cells perturbs their ability to respond to nerve N-acetylglucosaminyltransferase III (GlcNAc-TIII) is encoded by the growth factor (11), and overexpression in a glioma cell line inhibits Mgat3 gene and catalyzes the addition of the bisecting GlcNAc to the core of N-glycans. Mice lacking GlcNAc-TIII due to the insertion mutation epidermal growth factor receptor function (12). K562 cells expressing Mgat3tm1Pst (termed Mgat3neo), exhibit retarded progression of liver tu- a transfected Mgat3 gene are comparatively resistant to natural killer mors induced by diethylnitrosamine (DEN; M. Bhaumik et al., Cancer cell cytotoxicity and colonize spleen more effectively (13). In mice Res., 58: 2881–2887, 1998). This phenotype seemed to be due to a reduc- overexpressing a Mgat3 transgene in hepatocytes, a reduction in tion, in activity or amount, of a circulating glycoprotein(s) that enhances secretion of apolipoprotein and lipids from liver was reported (14). DEN-induced liver tumor progression. Here, we provide new evidence to Transgenic mice overexpressing a Mgat3 transgene in hematopoietic support this hypothesis. First, we show that mice with a deletion mutation ⌬ cells were found to have a defect in stroma-dependent hemopoiesis of the Mgat3 gene coding exon (Mgat3tmlJxm, termed Mgat3 ) also exhibit retarded progression of DEN-induced liver tumors.
    [Show full text]
  • Network Inference from Glycoproteomics Data Reveals New Reactions in the Igg Glycosylation Pathway
    ARTICLE DOI: 10.1038/s41467-017-01525-0 OPEN Network inference from glycoproteomics data reveals new reactions in the IgG glycosylation pathway Elisa Benedetti1, Maja Pučić-Baković2, Toma Keser 3, Annika Wahl4,5, Antti Hassinen6, Jeong-Yeh Yang7, Lin Liu7, Irena Trbojević-Akmačić2, Genadij Razdorov 2, Jerko Štambuk2, Lucija Klarić2,8,9, Ivo Ugrina 3,10,11, Maurice H.J. Selman12, Manfred Wuhrer 12, Igor Rudan 8, Ozren Polasek13,14, Caroline Hayward 9, Harald Grallert4,5,15, Konstantin Strauch16,17, Annette Peters5, Thomas Meitinger18, Christian Gieger4,5, Marija Vilaj2, Geert-Jan Boons7,19, Kelley W. Moremen7, Tatiana Ovchinnikova20, Nicolai Bovin20, Sakari Kellokumpu6, Fabian J. Theis 1,21, Gordan Lauc2,3 & Jan Krumsiek 1,14 Immunoglobulin G (IgG) is a major effector molecule of the human immune response, and aberrations in IgG glycosylation are linked to various diseases. However, the molecular mechanisms underlying protein glycosylation are still poorly understood. We present a data- driven approach to infer reactions in the IgG glycosylation pathway using large-scale mass- spectrometry measurements. Gaussian graphical models are used to construct association networks from four cohorts. We find that glycan pairs with high partial correlations represent enzymatic reactions in the known glycosylation pathway, and then predict new biochemical reactions using a rule-based approach. Validation is performed using data from a GWAS and results from three in vitro experiments. We show that one predicted reaction is enzymatically feasible and that one rejected reaction does not occur in vitro. Moreover, in contrast to previous knowledge, enzymes involved in our predictions colocalize in the Golgi of two cell lines, further confirming the in silico predictions.
    [Show full text]
  • Human Lectins, Their Carbohydrate Affinities and Where to Find Them
    biomolecules Review Human Lectins, Their Carbohydrate Affinities and Where to Review HumanFind Them Lectins, Their Carbohydrate Affinities and Where to FindCláudia ThemD. Raposo 1,*, André B. Canelas 2 and M. Teresa Barros 1 1, 2 1 Cláudia D. Raposo * , Andr1 é LAQVB. Canelas‐Requimte,and Department M. Teresa of Chemistry, Barros NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2829‐516 Caparica, Portugal; [email protected] 12 GlanbiaLAQV-Requimte,‐AgriChemWhey, Department Lisheen of Chemistry, Mine, Killoran, NOVA Moyne, School E41 of ScienceR622 Co. and Tipperary, Technology, Ireland; canelas‐ [email protected] NOVA de Lisboa, 2829-516 Caparica, Portugal; [email protected] 2* Correspondence:Glanbia-AgriChemWhey, [email protected]; Lisheen Mine, Tel.: Killoran, +351‐212948550 Moyne, E41 R622 Tipperary, Ireland; [email protected] * Correspondence: [email protected]; Tel.: +351-212948550 Abstract: Lectins are a class of proteins responsible for several biological roles such as cell‐cell in‐ Abstract:teractions,Lectins signaling are pathways, a class of and proteins several responsible innate immune for several responses biological against roles pathogens. such as Since cell-cell lec‐ interactions,tins are able signalingto bind to pathways, carbohydrates, and several they can innate be a immuneviable target responses for targeted against drug pathogens. delivery Since sys‐ lectinstems. In are fact, able several to bind lectins to carbohydrates, were approved they by canFood be and a viable Drug targetAdministration for targeted for drugthat purpose. delivery systems.Information In fact, about several specific lectins carbohydrate were approved recognition by Food by andlectin Drug receptors Administration was gathered for that herein, purpose. plus Informationthe specific organs about specific where those carbohydrate lectins can recognition be found by within lectin the receptors human was body.
    [Show full text]
  • MGAT5 Antibody (C-Term) Affinity Purified Rabbit Polyclonal Antibody (Pab) Catalog # Ap13815b
    10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 MGAT5 Antibody (C-term) Affinity Purified Rabbit Polyclonal Antibody (Pab) Catalog # AP13815b Specification MGAT5 Antibody (C-term) - Product Information Application WB, FC,E Primary Accession Q09328 Other Accession NP_002401.1 Reactivity Human Host Rabbit Clonality Polyclonal Isotype Rabbit Ig Antigen Region 652-680 MGAT5 Antibody (C-term) - Additional Information Gene ID 4249 Other Names Alpha-1, 6-mannosylglycoprotein All lanes : Anti-MGAT5 Antibody (C-term) at 6-beta-N-acetylglucosaminyltransferase A, 1:1000 dilution Lane 1: HepG2 whole cell Alpha-mannoside beta-1, lysate Lane 2: Jurkat whole cell lysate 6-N-acetylglucosaminyltransferase, Lysates/proteins at 20 µg per lane. GlcNAc-T V, GNT-V, Mannoside Secondary Goat Anti-Rabbit IgG, (H+L), acetylglucosaminyltransferase 5, Peroxidase conjugated at 1/10000 dilution. N-acetylglucosaminyl-transferase V, MGAT5, GGNT5 Predicted band size : 85 kDa Blocking/Dilution buffer: 5% NFDM/TBST. Target/Specificity This MGAT5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 652-680 amino acids from the C-terminal region of human MGAT5. Dilution WB~~1:1000 FC~~1:10~50 Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. MGAT5 Antibody (C-term) (Cat. #AP13815b) Storage flow cytometric analysis of NCI-H460 cells Maintain refrigerated at 2-8°C for up to 2 (right histogram) compared to a negative weeks. For long term storage store at -20°C control cell (left histogram).FITC-conjugated Page 1/3 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 in small aliquots to prevent freeze-thaw donkey-anti-rabbit secondary antibodies were cycles.
    [Show full text]
  • Mouse Mgat5 Knockout Project (CRISPR/Cas9)
    https://www.alphaknockout.com Mouse Mgat5 Knockout Project (CRISPR/Cas9) Objective: To create a Mgat5 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Mgat5 gene (NCBI Reference Sequence: NM_145128 ; Ensembl: ENSMUSG00000036155 ) is located on Mouse chromosome 1. 18 exons are identified, with the ATG start codon in exon 3 and the TAG stop codon in exon 18 (Transcript: ENSMUST00000038361). Exon 3 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for deficiencies in this gene have immune system abnormalities and reduced cancer growth and metastasis. Exon 3 starts from the coding region. Exon 3 covers 10.86% of the coding region. The size of effective KO region: ~383 bp. The KO region does not have any other known gene. Page 1 of 9 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 3 18 Legends Exon of mouse Mgat5 Knockout region Page 2 of 9 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of Exon 3 is aligned with itself to determine if there are tandem repeats. Tandem repeats are found in the dot plot matrix. The gRNA site is selected outside of these tandem repeats. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section downstream of Exon 3 is aligned with itself to determine if there are tandem repeats.
    [Show full text]